A member of The iQ Group Global, iQX Limited is an investment funds management company specialising in the bioscience sector that is committed to eradicating disease through capital investment.
IQX Limited
NSX:IQX ISIN:AU000000IQX4
News
iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
iQX Limited (NSX:IQX) has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Device Designation.
iQX Limited (NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, today announced the successful completion of a clinical validation study showcasing the efficacy of its rapid SARS-Cov-2 Antibody test.
iQX Limited (NSX:IQX) is pleased to announce that OncoTEX Inc has received licensing for a gold compound platform technology that induces the body's immune system to destroy cancer cells.
iQX Limited (NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, that LSBD's subsidiary GBS today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant.
iQX Limited (iQX Ltd) (NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository.
Notice is hereby given that an Extraordinary General Meeting (EGM) of iQX Limited (NSX:IQX) will be held at ParkRoyal Darling Harbour at 10.00am (AEST) on Tuesday 14 July 2020.
iQX Limited (iQX Ltd) (NSX:IQX) would like to announce a collaboration agreement between the Wyss Institute for Biologically Inspired Engineering, Harvard University, and Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which iQX Ltd holds a 19% equity position.
6,646 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 11) (Last 30 Days: 39) (Since Published: 6646)